Atypical glandular cells (AGC) often cause diagnostic uncertainty in cervicovaginal smears. To determine the incidence of significant pathologies associated with AGC on Papanicolaou test, AGC smears were correlated with subsequent biopsy diagnoses. A retrospective review of archives of our cytology files for cervicovaginal smears diagnosed as AGC from April 1998 to March 2001 was performed. In 9390 cervicovaginal smears, AGC were reported in 76 (0.81%) cases, with histologic follow-up in 42 patients (55.3%). Twenty-two patients (52.4%) had preneoplastic or neoplastic, squamous, or glandular lesions on histologic examination. Among them were cervical intraepithelial neoplasia, basal cell abnormality of undetermined significance, cervical adenocarcinoma, endometrial hyperplasia or adenocarcinoma, vaginal adenocarcinoma, endocervical glandular dysplasia, metastatic breast carcinoma, and simple nonvillous trophoblastic tissue. Therefore, presence of AGC in cervical smears may exhibit a spectrum of findings, ranging from benign/reactive changes to squamous or glandular premalignancy or malignancy. A majority of these lesions are squamous dysplasia, and a significant number of patients had glandular malignancy. The results of the current study underline the importance of follow-up for patients with the diagnosis of AGC. To our knowledge, this is the first report in Iran showing the significance of AGC diagnosis.
Atypical squamous cells of undetermined significance (ASCUS) on a cervical smear is a good marker for detecting underlying SIL and condyloma. Thus, immediate colposcopy and directed biopsy are appropriate follow-up procedures.
Acute oral hydration is a noninvasive, easily accessible and cheap intervention, and an effective way of increasing AFI.
Acardiac twin syndrome is a rare complication affecting monozygotic twins, where one twin fails to develop normally and completely. In this report, we present an acardiac fetus that was seen for evaluation at 26 weeks of gestation. Initial routine ultrasound examination suggested anomalies. The first detailed ultrasound demonstrated a normal fetus with appropriate growth plus an acardiac twin with a hypoplastic lower limb with subcutaneous edema and intestine-like organ near it. The pregnancy was followed with serial ultrasonography and spontaneous delivery occurred at term. A normal infant was born, and after delivery of the placenta, at the chorionic plate of the placenta there was a sac with diminished fluid, containing some loops of the intestine. A thin cord of one vascular channel was attached to the common placenta. In our literature review, this type of acardiac fetus has not been reported previously.
Oligohydramnios occurs in about 2.3% of pregnancies and is threatening to fetal health. Hydration has been hypothesized to be an effective way of decreasing the occurrence of the condition because the likelihood for oligohydramnios increases with maternal dehydration. Several studies have shown that both serum and oral hydration therapies are effective treatments for oligohydramnios. The amniotic fluid index (AFI) is the most commonly used quantitative indicator of amniotic fluid volume. This randomized controlled clinical trial evaluated the efficacy of acute maternal hydration on increasing AFI in 44 pregnant Iranian women who were diagnosed by sonography to have oligohydramnios (defined as 2.1 Ͻ AFI Ͻ 6 cm). The participants were randomly divided into 2 groups: an intervention group (n ϭ 22) receiving oral hydration (2 liters of water within 2 hours) and a control group (n ϭ 22) receiving routine amounts of water. AFI and urinary specific gravity were measured in both groups at baseline and following intervention.Before treatment, the mean AFI was 50.8 in the intervention group and 52.1 in the control group. After treatment, the mean AFI increased to 67.2 in the intervention group whereas the AFI in the control group (52.5) remained close to the baseline value (P Ͻ 0.001, t test ϭ 3.827). There was a marked increase in the mean urinary specific gravity after treatment (intervention: 13.4 vs. control: 1.68) (P Ͻ 0.001, t test ϭ 3.956).These findings are consistent with previous studies showing that acute oral hydration is an effective, noninvasive, easily accessible and inexpensive treatment to increase AFI. EDITORIAL COMMENT(Whether maternal hydration increases amniotic fluid volume has been evaluated in relatively few randomized studies. The first was performed by Kilpatrick et al. They randomized 40 women who had an AFI of less than 6 cm, but greater than 2 cm to one of 2 groups. The first group was instructed to drink 2 liters of water 2 to 4 hours before a repeat assessment of amniotic fluid volume which was performed either the same day as the initial assessment, or on the following day. Women in the second group were counseled to drink only their usual amount of liquid or just slightly more, and also underwent repeat amniotic fluid volume assessment the same or the following day. The involved sonographers were blinded to treatment group. Compliance with the interventions was reasonable but not perfect. Women in the 2 liters hydration group had a very modest improvement in their AFI, from a mean of 4.8 cm to 6.3 cm, whereas the AFI in the control group went from 4.8 cm to 5.1 cm (Obstet Gynecol 1991;78:1098).Yan-Rosenberg et al evaluated the effect of intravenous hydration on AFI. They randomized 44 women who were in the third trimester with an AFI of less than 6 cm to 2 L of intravenous normal saline, or to 20 mL of 1 ⁄2 normal saline. In both groups, the fluid was administered over 2 hours and a repeat AFI performed by the same sonographer 1 hour after the infusions were completed. In both groups, the ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.